Next Article in Journal
Cyclic versus Hemi-Bastadins. Pleiotropic Anti-Cancer Effects: from Apoptosis to Anti-Angiogenic and Anti-Migratory Effects
Previous Article in Journal
Technologies for the Synthesis of mRNA-Encoding Libraries and Discovery of Bioactive Natural Product-Inspired Non-Traditional Macrocyclic Peptides
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 18
Issue 3
10.3390/molecules18033529
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Terminalia chebula Extract Protects OGD-R Induced PC12 Cell Death and Inhibits LPS Induced Microglia Activation

by
Bhakta Prasad Gaire
1,
Nirmala Jamarkattel-Pandit
1,
Donghun Lee
1,
Jungbin Song
1,
Ji Young Kim
1,
Juyeon Park
2,
Soyoung Jung
1,
Ho-Young Choi
1 and
Hocheol Kim
1,*
1
Department of Herbal Pharmacology, Kyung Hee University, College of Oriental Medicine, Seoul 130-701, Korea
2
Korea Institute of Science and Technology for Eastern Medicine (KISTEM), NeuMed Inc., Seoul 130-701, Korea
*
Author to whom correspondence should be addressed.
Molecules 2013, 18(3), 3529-3542; https://doi.org/10.3390/molecules18033529
Submission received: 11 December 2012 / Revised: 9 March 2013 / Accepted: 12 March 2013 / Published: 19 March 2013
(This article belongs to the Section Natural Products Chemistry)
Browse Figures
Versions Notes

Abstract

:
Terminalia chebula, native to Southeast Asia, is a popular medicinal plant in Ayurveda. It has been previously reported to have strong antioxidant and anti-inflammatory efficacy. In this study, we aimed to investigate if fruit extract from T. chebula might protect neuronal cells against ischemia and related diseases by reduction of oxidative damage and inflammation in rat pheochromocytoma cells (PC12) using in vitro oxygen-glucose deprivation followed by reoxygenation (OGD-R) ischemia and hydrogen peroxide (H2O2) induced cell death. Cell survival was evaluated by a 2-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Free radical scavenging, lipid peroxidation and nitric oxide inhibition were measured by diphenyl-1-picrylhydrazyl (DPPH), thiobarbituric acid (TBA) and Griess reagent, respectively. We found that T. chebula extract: (1) increases the survival of cells subjected to OGD-R by 68%, and H2O2 by 91.4%; (2) scavenges the DPPH free radical by 96% and decreases malondialdehyde (MDA) levels from 237.0 ± 15.2% to 93.7 ± 2.2%; (3) reduces NO production and death rate of microglia cells stimulated by lipopolysaccharide (LPS). These results suggest that T. chebula extract has the potential as a natural herbal medicine, to protect the cells from ischemic damage and the possible mechanism might be the inhibition of oxidative and inflammatory processes.

Graphical Abstract

1. Introduction

Natural antioxidants, from medicinal or edible plants, have recently received much attention as promising agents for reducing the risk of oxidative stress-induced neurological diseases [1,2]. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are the main source of free radicals, and they lead to serious damage causing neurodegeneration in the pathogenesis of neurological disorders such as Alzheimer’s disease, Parkinson’s disease and strokes [3,4,5]. Overproduction of ROS, during ischemia/reperfusion, causes an imbalance between oxidative and anti-oxidative processes leading to mitochondrial dysfunction, excitotoxicity, lipid peroxidation, and inflammation. Therapeutic efforts aimed to counteract ROS or inhibit their formation, have been shown to be beneficial in various neuro-degenerative diseases, including ischemia [6].
Terminalia chebula Retz. (Combretaceae), commonly known as chebulic myrobalan, is a popular medicinal plant in the Ayurvedic system of medicine. The main compounds from T. chebula, such as gallic acid, ellagic acid, chebulanin, chebulinic acid, rutin casuarinin, and quercetin, were reported to possess antioxidant effects [7,8]. Traditionally, T. chebula has been used to treat kidney and urinary disorders, nervous disorders, colic pain, chronic cough, sore throat, asthma, etc. It is also used as laxative, antitussive, diuretic, digestive, antidiabetic, and as a cardiotonic remedy [9,10]. T. chebula has been reported to exhibit anticancer [11], antidiabetic [12], antimutagenic [13], antibacterial [14] and cardio-protective activities [15]. T. chebula is also reported to possess strong anti-inflammatory activity [16].
Based on the information regarding antioxidant and anti-inflammatory effects, we hypothesized that fruit of T. chebula extract may have protective effects on neuronal cell death against ischemia and related diseases. In this study, we aimed to investigate the protective effect of T. chebula extract against OGD-R and hydrogen peroxide (H2O2) induced cell injury on the rat pheochromocytoma cell line (PC12 cells). The reason for choosing PC12 cells is that, they display phenotypic characteristics of adrenal chromaffin cells and sympathetic neurons and therefore, PC12 cells are a well-known model for neuronal differentiation [17,18]. OGD-R, a well-accepted in vitro ischemia model [19,20], was used to evaluate the protective effect of T. chebula extract. H2O2 induced cell death; an extensively used in vitro oxidative stress model [21,22], was used to evaluate the effect of T. chebula extract in PC12 cells. Furthermore, the activation of the primary microglia is one of the major reasons of cellular inflammation in ischemic condition and lipopolysaccharide (LPS) activated BV2 cells are reported as the suitable alternatives for primary microglia in the culture or animal experiments [23]. Therefore, we investigated the inhibitory effect of T. chebula extract on LPS activated microglia cells (BV2 cell). We also determined the diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging, lipid peroxidation and nitric oxide (NO) inhibition activity of T. chebula extract.

2. Results

2.1. HPLC Analysis and Total Phenol Content of T. chebula Extract

The 3D HPLC spectrum of T. chebula extract is shown in Figure 1. The major polyphenols isolated from the T. chebula extract were gallic acid and ellagic acid.
Molecules 18 03529 g001 550
Figure 1. 3D HPLC spectrum of T. chebula extract showing gallic acid and ellagic acid.
Figure 1. 3D HPLC spectrum of T. chebula extract showing gallic acid and ellagic acid.
Molecules 18 03529 g001

2.2. DPPH Radical Scavenging Activity of T. chebula Extract

T. chebula extract showed dose dependent radical scavenging activities with a maximum of 96% inhibition against DPPH radical at 100 μg/mL. The effective concentration of T. chebula extract to scavenge 50% of DPPH free radical (EC50) was found as 5.5 ± 1.1 μg/mL. Ascorbic acid (EC50 of 4.7 ± 0.01 μg/mL) was used as a positive control. Table 1 showed the content of gallic acid, ellagic acid and total phenols in T. chebula extract.
Table
Table 1. Total phenols gallic and ellagic acid yield from T. chebula extract.
Table 1. Total phenols gallic and ellagic acid yield from T. chebula extract.
Total Phenol (mg GAE/g)Gallic acid (mg/g)Ellagic acid (mg/g)
787.1 ± 20.829.8 ± 2.825.5 ± 2.2

2.3. Effect of T. chebula Extract in PC12 Cells against OGD-R Induced Cell Death

The survival of cells after treatment of T. chebula extract was measured by an MTT assay. T. chebula extract (at 0.1–10 μg/mL) didn’t show any cytotoxic effects on PC12 cells (Figure 2A). To examine whether T. chebula extract protects against OGD-R induced cell death, PC12 cells were incubated without glucose solution in the hypoxia chamber for 4 h followed by 24 h of reoxygenation with glucose solution in normal incubator. Different concentrations of T. chebula extract were treated 30 min before and during 4 h OGD. Cell viability in OGD group was 50.4 ± 1.5% whereas cell viability in T. chebula extract treated cells (at 0.1, 1, 10 μg/mL) were 62.4 ± 2.2% (p < 0.05), 68.0 ± 2.0% (p < 0.01), and 54.8 ± 1.2% (p < 0.05) respectively, as compared to the control group (set 100%). Baicalein at 0.27 μg/mL (1 μM) treated cells showed 74.0 ± 2.8% (p < 0.001) cell viability against OGD-R (Figure 2B).
Molecules 18 03529 g002 550
Figure 2. Effect of T. chebula extract on PC12 cells. (A) Cytotoxic effect of T. chebula extract on PC12 cells. Different concentrations of T. chebula extract were treated on PC12 cells for 28 h in normal condition. (B) Effect of T. chebula extract against OGD-R induced cell death on PC12 cells. PC12 cells were exposed to OGD for 4 h followed by re-oxygenation for 24 h. Different concentrations of T. chebula extract were treated 30 min before and during 4 h of OGD. PC12 cells viability was measured by MTT assay. Control group served as 100%, and data obtained in other groups were calculated as percentage of control accordingly. * p < 0.05, ** p < 0.01 and *** p < 0.001.
Figure 2. Effect of T. chebula extract on PC12 cells. (A) Cytotoxic effect of T. chebula extract on PC12 cells. Different concentrations of T. chebula extract were treated on PC12 cells for 28 h in normal condition. (B) Effect of T. chebula extract against OGD-R induced cell death on PC12 cells. PC12 cells were exposed to OGD for 4 h followed by re-oxygenation for 24 h. Different concentrations of T. chebula extract were treated 30 min before and during 4 h of OGD. PC12 cells viability was measured by MTT assay. Control group served as 100%, and data obtained in other groups were calculated as percentage of control accordingly. * p < 0.05, ** p < 0.01 and *** p < 0.001.
Molecules 18 03529 g002

2.4. Effect of T. chebula Extract in H2O2 Treated PC12 Cells

To determine whether T. chebula extract protects cells against oxidative stress induced cell death, PC12 cells were exposed to H2O2 for 24 h. The toxicity of H2O2 in PC12 cells was found to be concentration and time-dependent (data not shown). Cell viability in the H2O2 (200 μM) treated group was 70.4 ± 1.5% and that in T. chebula extract treated cells (at 0.01, 0.1, 1 μg/mL) was 80.6 ± 3.6% (p < 0.05), 91.4 ± 3.6% (p < 0.005), and 86.9 ± 4.4% (p < 0.01) respectively, as compared to the control group (100%) (Figure 3A). Baicalein at 0.27 μg/mL (1 μM) treated cells showed 84.0 ± 2.9% (p < 0.05) cell viability against H2O2. Previous study [24] was reported that methanol extract of T. chebula at 0.5 μM showed 100.8 ± 9.2% (p < 0.01) cell viability.

2.5. Effect of T. chebula Extract in Lipid Peroxidation

The TBA colorimetric assay was performed to determine whether T. chebula extract can inhibit the formation of MDA induced by H2O2. The cells treated with H2O2 significantly increased MDA levels as compared with control cells (set 100%). Pretreatment of T. chebula extract at 0.1 μg/mL and 1 μg/mL significantly reduced MDA level from 237.0 ± 15.2% in the H2O2 treated group to 115.8 ± 5.8% (p < 0.001) and 93.7 ± 2.2% (p < 0.001) respectively (Figure 3B).
Molecules 18 03529 g003 550
Figure 3. Effect of T. chebula extract on H2O2-induced cell death and lipid peroxidation assay. PC12 cells were exposed to 200 μM H2O2 for 24 h. Different concentrations of T. chebula extract were treated 2 h before and during H2O2 exposure. Control group served as 100%, and data obtained in other groups were calculated as percentage of control accordingly. (A) PC12 cells viability was measured by MTT assay. (B) Lipid peroxidation assay (MDA level) was measured by thiobarbutic assay. ** p < 0.01, and *** p < 0.001.
Figure 3. Effect of T. chebula extract on H2O2-induced cell death and lipid peroxidation assay. PC12 cells were exposed to 200 μM H2O2 for 24 h. Different concentrations of T. chebula extract were treated 2 h before and during H2O2 exposure. Control group served as 100%, and data obtained in other groups were calculated as percentage of control accordingly. (A) PC12 cells viability was measured by MTT assay. (B) Lipid peroxidation assay (MDA level) was measured by thiobarbutic assay. ** p < 0.01, and *** p < 0.001.
Molecules 18 03529 g003

2.6. Effect of T. chebula Extract in LPS Induced Microglia Cell Activation and NO Inhibition

In order to elucidate the effect of T. chebula extract against LPS induced microglia activation, BV2 cells were treated with LPS. Cell viability, after treatment of LPS (1 μg/mL), was found as 68.7 ± 2.0% whereas T. chebula extract (at 0.1, 1, and 10 μg/mL) treated cells showed viability of 76.8 ± 4.9%, 78.2 ± 2.2% (p < 0.05), and 87.1 ± 4.3% (p < 0.01) respectively (Figure 4A). The amount of NO released by BV2 cells was 3.3 ± 0.5 μM in control cells, 19.2 ± 1.1 μM (p < 0.001) in LPS treated cells, and 16.6 ± 0.7 μM, 10.0 ± 0.7 μM (p < 0.001) and 7.2 ± 0.9 μM (p < 0.001) in T. chebula extract (0.1, 1, 10 μg/mL) treated cells, respectively (Figure 4B). Curcumin at 1 μg/mL showed 94.3 ± 5.2% (p < 0.001) cell viability and 8.7 ± 1.2 μM (p < 0.001) NO release in BV2 cells.
Molecules 18 03529 g004 550
Figure 4. Effect of T. chebula extract on LPS-induced cell death and NO inhibition assay. BV2 cells were exposed to LPS (1 μg/mL) for 24 h. Different concentrations of T. chebula extract were treated 2 h before and during LPS exposure. (A) Cell viability was measured by MTT assay. Control group served as 100%, and data obtained in other groups were calculated as percentage of control accordingly. (B) Cell-conditioned supernatants were collected and the production of NO in the supernatants was measured using Griess reagent. NO production was calculated by using standard nitrite. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Figure 4. Effect of T. chebula extract on LPS-induced cell death and NO inhibition assay. BV2 cells were exposed to LPS (1 μg/mL) for 24 h. Different concentrations of T. chebula extract were treated 2 h before and during LPS exposure. (A) Cell viability was measured by MTT assay. Control group served as 100%, and data obtained in other groups were calculated as percentage of control accordingly. (B) Cell-conditioned supernatants were collected and the production of NO in the supernatants was measured using Griess reagent. NO production was calculated by using standard nitrite. * p < 0.05, ** p < 0.01, and *** p < 0.001.
Molecules 18 03529 g004

3. Discussion

In the present study, fruit extract of T. chebula significantly reduced PC12 cell death induced by 4 h of OGD followed by 24 h of reoxygenation and 24 h exposure of H2O2. T. chebula extract showed the strong scavenging activity against DPPH free radicals and markedly reduced the H2O2-induced MDA production. T. chebula extract also reduced LPS induced cell death and inhibited the production of NO by BV2 cells in a dose dependent manner.
As OGD-R mimics tissue ischemia, it results in the production of ROS, release from glutamate toxicity, and inflammatory cytokines [25,26]. Generations of the free radicals, such as, superoxide and superoxide-derived oxidants have been invoked as key mediators of tissue injury during ischemia-reperfusion [27]. Cellular injury followed by ischemic reperfusion is a complex pathophysiological event associated with impairment of multiple vascular and cellular responses. Oxidative damage due to the ROS/RNS play the vital role to initiate a wide range of intracellular stress signaling processes that culminate in excessive cytokine and chemokine response, adhesion molecule upregulation, etc. [28]. Once the ROS/RNS are produced within the cells, oxidative cascades of events take place simultaneously, including free radical production, sudden start and aggravation of mitochondrial respiratory chains, excitotoxicity, enzymatic changes, and the stimulation of the inflammatory processes [29]. Among such cascades, oxidative stress and inflammation play the key role for the cellular damage. The compounds having antioxidant, anti-inflammatory, anti-glutamate activity show protective activity against hypoxia induced cell damage [26,30,31,32].
T. chebula extract significantly protected the PC12 cells against OGD-R. The exposure of PC12 cells to 4 h of OGD followed by 24 h of re-oxygenation resulted decrease in cell viability as compared to control (non-OGD) cells. Incubation of PC12 cells with T. chebula extract, 30 min before and during OGD period, led to significant increase in cell viability. It is reported that, OGD mediates the oxidative stress in the cells by activating the different oxidative cascades such as activation of lipoxygenase, IκB kinase, nuclear factor-κB, and OGD-R is the major source of ROS in ischemia [33,34]. In our study, T. chebula extract markedly scavenged the nitrogen-centered free radical DPPH (by 96%) in a dose dependent manner, similar to that of ascorbic acid, so the potential nature of antioxidant activity of T. chebula extract might be the key factor to sequester the ROS, that are generated in the ischemic cascades, like OGD-R.
The maximum protective effect of T. chebula extract (70%) against H2O2 induced PC12 cell death, was found to be significantly higher than that of the positive control, baicalein (46.3%). H2O2 is not a free radical and has a limited reactivity; however, it is the major precursor of the highly reactive hydroxyl radical. Previous studies have shown a close association between H2O2 and neurodegenerative disease, and it has been suggested that H2O2 levels are increased during pathological conditions, such as ischemia [35,36]. ROS, such as H2O2, readily damage biological molecules that can eventually lead to apoptotic or necrotic cell death [37]. In our study, interestingly, the extent of cell protection by T. chebula extract after H2O2 induced cell death was higher in less concentration of extract than that in higher concentration (Figure 3A). The mechanism of cell protection by T. chebula extract, against H2O2 induced cell death is largely due to the antioxidant efficacy of polyphenols present in T. chebula, such as quercetin, gallic acid and ellagic acids. These polyphenols are reported to show pro-oxidant activity at higher concentrations [38,39]. This might explain the lesser protective effect of T. chebula extract at higher concentration (1 μg/mL).
T. chebula extract markedly scavenged the nitrogen-centered free radical DPPH in a dose dependent manner. From HPLC analysis, it was observed that main phenolic compounds in T. chebula are gallic acid and ellagic acid, which are well-known natural antioxidants [40]. Plant polyphenols are multifunctional in the sense that they can act as reducing agents, hydrogen atom donors, and singlet oxygen scavengers [41]. The DPPH radical scavenging activity of T. chebula is mostly related to the hydroxyl group in gallic acid and ellagic acid.
Our results showed that MDA production during H2O2 treatment was significantly inhibited by T. chebula. H2O2 is believed to be the major precursor for highly reactive free radicals, expressed indirectly by the increase in MDA levels, which is one of the most important organic expressions of oxidative stress in various neuronal diseases including ischemia [42]. Oxidative stress induces cellular damage and lipid peroxidation, which may lead to alterations in membranes and produce significant changes in their biophysical function [43]. Previous studies have shown that the radical scavengers and inhibitors of lipid peroxidation can ameliorate ischemic cell damage [5,44]. Therefore, antioxidant effect through the inhibition of lipid peroxidation and free radical scavenging could be the possible protective mechanisms of T. chebula against ischemia and H2O2 induced cell death.
T. chebula extract inhibited the accumulation of NO by 76.2%, at 10 μg/mL. LPS activated BV2 cells release NO in the culture medium which is recognized as a mediator and regulator in pathological reactions, especially in acute inflammatory responses [45]. In addition to ROS, overproduction of NO also plays an important role in various models of inflammation [46,47,48]. The reaction of NO with superoxide anion forms peroxynitrite [49], a potent cytotoxic oxidant eliciting lipid peroxidation and cellular damage [50]. Activated microglia is thought to be involved in neuronal inflammation by overproducing various bioactive molecules such as NO, ROS and pro-inflammatory cytokines [51]. T. chebula extract significantly inhibited NO release by LPS activated BV2 cells, elucidating that it can inhibit the activation of microglia. Therefore, anti-inflammatory effect through the inhibition of NO release could be another possible protective mechanism of T. chebula against ischemia.
Besides these, T. chebula and its active compounds gallic acid and ellagic acids are previously reported to inhibit cytochrome p450 enzyme and protect against mitochondrial dysfunction [52,53]. T. chebula treatment significantly increased the level of Cytochrome C oxidase and other mitochondrial enzymes. Gallic acid down-regulates the protein expression and activity of caspase-3, an essential effector molecule in the course of programmed cell death [54]. T. chebula is also reported to inhibit inducible nitric oxide synthesis by decreasing iNOS protein and iNOS mRNA levels suggesting the possible intercellular mechanism of T. chebula extracts and its active constituents [55]. Taken together, the protective efficacy of the T. chebula extract against OGD-R induced PC12 cell death and the inhibition of activated microglia must be due to the antioxidant and anti-inflammatory potential of T. chebula extract and its polyphenols.

4. Experimental

4.1. Plant Material and Chemicals

The fruits of T. chebula were collected from Pokhara, Nepal after proper identification by the experts. A voucher specimen (HP203) was deposited in the Herbarium of the Kyung Hee University, College of Oriental Medicine, Seoul, South Korea. Dulbecco’s modified Eagle’s Medium (DMEM), LPS, Escherichia coli (0127:138), 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT), 2,2'-, DPPH, gallic acid, ellagic acid, thiobarbituric acid (TBA), butylated hydroxytoluene (BHT), dimethyl sulfoxide (DMSO) and Griess reagent were all purchased from Sigma Chemical Co. (St. Louis, MO, USA), Fetal Bovine Serum (FBS), penicillin and streptomycin were obtained from Gibco BRL (Grand Island, NY, USA). All reagents and solvents used were of HPLC grade, unless specified.

4.2. Extraction of Plant Material

T. chebula fruit powder (100 g) was extracted under reflux with 70% methanol (1000 mL). The extract was evaporated with a rotary evaporator under reduced pressure to remove the organic solvent and then lyophilized until dryness. A stock solution of extract was prepared in DMSO and deionized water, respectively. Final DMSO concentration did not exceed 0.1% (v/v) in all treatments.

4.3. HPLC Analysis of T. chebula Extract

Methanol extract of T. chebula was analyzed by the HPLC with a 600 pump (Waters, Milford, MA, USA) using 250 mm × 4 mm HypersilTM Gold C18 column (ThermoElectron, Bellefonte, PA, USA), at a flow rate of 1 mL/min under the following conditions: solvent A (0.5% v/v H3PO4) and solvent B (CH3CN); a linear gradient from 5% to 50% v/v of solvent B in A for 60 min. The isolated compounds were monitored with photodiode array detector (926, Waters). Content of major compounds was calculated by comparing with the standard compounds.

4.4. Free Radical Scavenging Activity and Total Phenol Content in T. chebula Extract

Free radical scavenging activity was measured spectrophotometrically by DPPH free radical scavenging assay [56] using ascorbic acid as a positive control. Phenolic compounds in the T. chebula extracts were determined by the colorimetric assay as described previously [57] with some modifications. Briefly, 1 mL of sample was mixed with an equal volume of Folin and Ciocalteu’s phenol reagent. After 3 min, 1 mL of saturated sodium carbonate solution was added to the mixture. After 90 min of reaction, the optical density (OD) was measured on a plate reader (SPECTRA max Plus384, CA, USA) at 725 nm. Gallic acid (10–500 mg/L) was used for calculation, and the results were expressed as mg of gallic acid equivalents (GCE) per gram of extract.

4.5. Cell Culture

PC12 cells and BV2 cells were obtained from the Medical Department, Kyung Hee University, Seoul, Korea, and maintained at 37 °C in a humidified atmosphere containing 5% CO2. PC12 cells were seeded at a density of 1.5 × 103 cells/well whereas BV2 cells were seeded at a density of 5 × 104 cells/well and cultured at 37 °C in DMEM is supplemented with 10% heat-inactivated FBS, penicillin (1 × 105 U/L) and streptomycin (100 mg/L) in a 5% CO2 incubator.

4.6. Oxygen-Glucose Deprivation Followed by re-Oxygenation

Oxygen-glucose deprivation followed by re-oxygenation experiments were carried out 24 h after seeding the cells. For the measurement of cytotoxic effects, PC12 cells were treated with T. chebula extract (at 0.1, 1, 10 μg/mL) and incubated for 28 h. For OGD injury, PC12 cells were first washed with phosphate buffer saline (PBS, pH 7.2) then with glucose-free DMEM. The cultures were then placed in fresh glucose free DMEM and kept in a hypoxic chamber (Forma Science, UK) containing 95% N2 and 5% CO2 for 4 h. At the end of the exposure period, glucose solution was added, and the cells were incubated (5% CO2 at 37 °C) for an additional 24 h. Samples of different concentrations were treated 30 min before and during OGD exposure. The control group was treated with the same amounts of serum free glucose DMEM and incubated. Baicalein, a potent antioxidative and neuroprotective compound [58] was used as a positive control.

4.7. H2O2 Induced Cell Injury

For H2O2 treatment, PC12 cells were washed with FBS free DMEM. Dilution of H2O2 was made from a 30% stock solution into DMEM just prior to each experiment and 200 μM solution added to the cells. The culture plates were incubated for an additional 24 h. Samples of different concentrations were treated 2 h before and during H2O2 exposure. Control group (without H2O2) was incubated under the same conditions.

4.8. Lipid Peroxidation Assay

Malondialdehyde (MDA), the most abundant lipid peroxidation product from PC12 cells, was measured using the TBA colorimetric assay. Briefly, 24 h after the treatment of the cells with H2O2 (200 μM) in the presence or absence of T. chebula extract (0.1 and 1 μg/mL), cultures were washed with ice-cold PBS, pooled in 0.1 mol/L PBS-5% Triton X-100 buffered solution, and incubated for about 1 h at 37 °C. Trichloroacetic acid (350 μL; 20% w/v) was added to 250 μL of cellular lysate and centrifuged (1,000 × g at 4 °C for 10 min). Aliquots (450 μL) of supernatant were mixed with equal volume of 0.5% (w/v) TBA. The mixture was boiled at 100 °C for 30 min. After cooling MDA formation was measured at 520 nm and the results were expressed as a percentage of the control group.

4.9. LPS-Induced Microglia Activation and the Measurement of NO

For LPS induced cell death and nitric oxide inhibitory assay of T. chebula extract, BV2 cells were incubated with/without 1 μg/mL of LPS, in the absence or presence of different sample solutions for 24 h. For the measurement of NO produced by activated cells, 90 μL of the supernatant from the BV2 cells was mixed with equal volume of the Griess reagent. The OD was measured at 540 nm. Curcumin, a potent anti-inflammatory compound [59] was used as a positive control.

4.10. Cell Viability

Cell viability was evaluated by observing the ability of viable cells to reduce yellow colored MTT to purple colored formazan. MTT was dissolved in DMEM and added to the culture at a final concentration of 0.5 mg/mL. After an additional 2 h of incubation, the media was carefully removed and 100 µL DMSO was added to each well. The OD was measured on a plate reader at 570 nm. Results were expressed as a percentage of the control group.

4.11. Statistical Analysis

All results are presented as mean ± S.E.M. Significant differences between experimental groups were determined by using one way ANOVA followed by the Tukey’s post hoc test using GraphPad Prism 4 (GraphPad Software Inc., La Jolla, CA, USA). p < 0.05 is considered as statistically significant for the experimental analysis. Each experiment was performed at triplicate.

4. Conclusions

In conclusion, T. chebula extract showed a protective effect against OGD-R, H2O2 and LPS induced cell death. T. chebula has an antioxidative and anti-inflammatory activity which could be the possible mechanism for the protection of cells against ischemia. Our results suggest that T. chebula fruit could be the useful remedy for ischemia, oxidative stress and activated microglia-induced secondary damage, which occurs in many neurodegenerative diseases. The exact protective mechanism of T. chebula extract against OGD-R is unknown, however, it can be estimated that the protective effect of T. chebula might be due to its antioxidative and anti-inflammatory effects. Further study is necessary to evaluate the protective effect of T. chebula extract on in vivo ischemia.

Acknowledgments

This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (B110072), and by grants from the Second Stage of Brain Korea 21 Project (Ministry of Education, Korea).

References

  1. Mates, J.M.; Segura, J.A.; Alonso, F.J.; Marquez, J. Natural antioxidants: Therapeutic prospects for cancer and neurological diseases. Mini Rev. Med. Chem. 2009, 9, 1202–1214. [Google Scholar] [CrossRef]
  2. Kim, H. Neuroprotective herbs for stroke therapy in traditional eastern medicine. Neurol. Res. 2005, 27, 287–301. [Google Scholar] [CrossRef]
  3. Uttara, B.; Singh, A.V.; Zamboni, P.; Mahajan, R.T. Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7, 65–74. [Google Scholar] [CrossRef]
  4. Devasagayam, T.P.; Tilak, J.C.; Boloor, K.K.; Sane, K.S.; Ghaskadbi, S.S.; Lele, R.D. Free radicals and antioxidants in human health: Current status and future prospects. J. Assoc. Physicians India 2004, 52, 794–804. [Google Scholar]
  5. Willcox, J.K.; Ash, S.L.; Catignani, G.L. Antioxidants and prevention of chronic disease. Crit Rev. Food Sci. Nutr. 2004, 44, 275–295. [Google Scholar] [CrossRef]
  6. Wang, Z.; An, L.J.; Duan, Y.L.; Li, Y.C.; Jiang, B. Catalpol protects rat pheochromocytoma cells against oxygen and glucose deprivation-induced injury. Neurol. Res. 2008, 30, 106–112. [Google Scholar] [CrossRef]
  7. Zafrilla, P.; Ferreres, F.; Tomas-Barberan, F.A. Effect of processing and storage on the antioxidant ellagic acid derivatives and flavonoids of red raspberry (Rubus idaeus) jams. J. Agric. Food Chem. 2001, 49, 3651–3655. [Google Scholar] [CrossRef]
  8. Cheng, H.Y.; Lin, T.C.; Yu, K.H.; Yang, C.M.; Lin, C.C. Antioxidant and free radical scavenging activities of Terminalia chebula. Biol. Pharm. Bull. 2003, 26, 1331–1335. [Google Scholar] [CrossRef]
  9. Kirtikar, K.R.; Basu, B.D. Terminalia chebula. In Indian Medicinal Plants; Kirtikar, K.R., Basu, B.D., Eds.; Lalit Mohan Basu Publications: Allahabad, India, 1935; pp. 1020–1023. [Google Scholar]
  10. Reddy, D.B.; Reddy, T.C.; Jyotsna, G.; Sharan, S.; Priya, N.; Lakshmipathi, V.; Reddanna, P. Chebulagic acid, a COX-LOX dual inhibitor isolated from the fruits of Terminalia chebula Retz., induces apoptosis in COLO-205 cell line. J. Ethnopharmacol. 2009, 124, 506–512. [Google Scholar] [CrossRef]
  11. Saleem, A.; Husheem, M.; Harkonen, P.; Pihlaja, K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula Retz. fruit. J. Ethnopharmacol. 2002, 81, 327–336. [Google Scholar] [CrossRef]
  12. Rao, N.K.; Nammi, S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC Complement. Altern. Med. 2006, 6, 17. [Google Scholar] [CrossRef]
  13. Kaur, S.; Grover, I.S.; Singh, M. Antimutagenicity of hydrolyzable tannins from Terminalia chebula in Salmonella typhimurium. Mutat. Res. 1998, 419, 169–179. [Google Scholar] [CrossRef]
  14. Kannan, P.; Ramadevi, S.R.; Hopper, W. Antibacterial activity of Terminalia chebula fruit extract. Afr. J. Microbiol. Res. 2009, 3, 180–184. [Google Scholar]
  15. Suchalatha, S.; Shyamala Devi, C.S. Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol. Indian J. Exp. Biol. 2004, 42, 174–178. [Google Scholar]
  16. Das, N.D.; Jung, K.H.; Park, J.H.; Mondol, M.A.; Shin, H.J.; Lee, H.S.; Park, K.S.; Choi, M.R.; Kim, K.S.; Kim, M.S.; Lee, R.R.; Chai, Y.G. Terminalia chebula extract acts as a potential NF-κB inhibitor in human lymphoblastic T cells. Phytother. Res. 2011, 25, 927–934. [Google Scholar] [CrossRef]
  17. Garg, M.K.; Kharb, S.; Brar, K.S.; Gundgurthi, A.; Mittal, R. Medical management of pheochromocytoma: Role of the endocrinologist. Indian J. Endocrinol. Metab. 2011, 15, S329–S336. [Google Scholar] [CrossRef]
  18. Isoda, H.; Talorete, T.P.; Kimura, M.; Maekawa, T.; Inamori, Y.; Nakajima, N.; Seki, H. Phytoestrogens genistein and daidzin enhance the acetylcholinesterase activity of the rat pheochromocytoma cell line PC12 by binding to the estrogen receptor. Cytotechnology 2002, 40, 117–123. [Google Scholar] [CrossRef]
  19. Yu, S.; Liu, M.; Gu, X.; Ding, F. Neuroprotective effects of salidroside in the PC12 cell model exposed to hypoglycemia and serum limitation. Cell. Mol. Neurobiol. 2008, 28, 1067–1078. [Google Scholar] [CrossRef]
  20. Prass, K.; Ruscher, K.; Karsch, M.; Isaev, N.; Megow, D.; Priller, J.; Scharff, A.; Dirnagl, U.; Meisel, A. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 2002, 22, 520–525. [Google Scholar]
  21. Rhee, S.G. Redox signaling: Hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 1999, 31, 53–59. [Google Scholar] [CrossRef]
  22. Giorgio, M.; Trinei, M.; Migliaccio, E.; Pelicci, P.G. Hydrogen peroxide: A metabolic by-product or a common mediator of ageing signals? Nat. Rev. Mol. Cell Biol. 2007, 8, 722–728. [Google Scholar] [CrossRef]
  23. Henn, A.; Lund, S.; Hedtjarn, M.; Schrattenholz, A.; Porzgen, P.; Leist, M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 2009, 26, 83–94. [Google Scholar]
  24. Chang, C.L.; Lin, C.S. Phytochemical composition, antioxidant activity, and neuroprotective effect of Terminalia chebula Retzius extract. Evid Based Complement. Alternat. Med. 2012, 2012, 125247. [Google Scholar]
  25. Bruno, V.M.; Goldberg, M.P.; Dugan, L.L.; Giffard, R.G.; Choi, D.W. Neuroprotective effect of hypothermia in cortical cultures exposed to oxygen-glucose deprivation or excitatory amino acids. J. Neurochem. 1994, 63, 1398–1406. [Google Scholar]
  26. Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 1999, 79, 1431–1568. [Google Scholar]
  27. Zimmerman, B.J.; Grisham, M.B.; Granger, D.N. Role of oxidants in ischemia/reperfusion-induced granulocyte infiltration. Am. J. Physiol. 1990, 258, G185–G190. [Google Scholar]
  28. Toledo-Pereyra, L.H.; Lopez-Neblina, F.; Toledo, A.H. Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann. Transplant. 2004, 9, 81–83. [Google Scholar]
  29. Singh, G.; Siddiqui, M.A.; Khanna, V.K.; Kashyap, M.P.; Yadav, S.; Gupta, Y.K.; Pant, K.K.; Pant, A.B. Oxygen glucose deprivation model of cerebral stroke in PC-12 cells: Glucose as a limiting factor. Toxicol. Mech. Methods 2009, 19, 154–160. [Google Scholar] [CrossRef]
  30. Lee, H.H.; Yang, L.L.; Wang, C.C.; Hu, S.Y.; Chang, S.F.; Lee, Y.H. Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res. 2003, 986, 103–113. [Google Scholar] [CrossRef]
  31. Son, D.; Lee, P.; Lee, J.; Kim, H.; Kim, S.Y. Neuroprotective effect of wogonin in hippocampal slice culture exposed to oxygen and glucose deprivation. Eur. J. Pharmacol. 2004, 493, 99–102. [Google Scholar] [CrossRef]
  32. Shi, H.; Liu, S.; Miyake, M.; Liu, K.J. Ebselen induced C6 glioma cell death in oxygen and glucose deprivation. Chem. Res. Toxicol. 2006, 19, 655–660. [Google Scholar] [CrossRef]
  33. Serajuddin, A.T.; Sheen, P.C.; Augustine, M.A. Common ion effect on solubility and dissolution rate of the sodium salt of an organic acid. J. Pharm. Pharmacol. 1987, 39, 587–591. [Google Scholar] [CrossRef]
  34. Abramov, A.Y.; Scorziello, A.; Duchen, M.R. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J. Neurosci. 2007, 27, 1129–1138. [Google Scholar] [CrossRef]
  35. Behl, C.; Davis, J.B.; Lesley, R.; Schubert, D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994, 77, 817–827. [Google Scholar] [CrossRef]
  36. Hyslop, P.A.; Zhang, Z.; Pearson, D.V.; Phebus, L.A. Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: Correlation with the cytotoxic potential of H2O2 in vitro. Brain Res. 1995, 671, 181–186. [Google Scholar] [CrossRef]
  37. Gardner, A.M.; Xu, F.H.; Fady, C.; Jacoby, F.J.; Duffey, D.C.; Tu, Y.; Lichtenstein, A. Apoptotic vs. Nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Radic Biol Med 1997, 22, 73–83. [Google Scholar] [CrossRef]
  38. Fukumoto, L.R.; Mazza, G. Assessing antioxidant and prooxidant activities of phenolic compounds. J. Agric. Food Chem. 2000, 48, 3597–3604. [Google Scholar] [CrossRef]
  39. Decker, E.A. Phenolics: Prooxidants or antioxidants? Nutr. Rev. 1997, 55, 396–398. [Google Scholar] [CrossRef]
  40. Chen, C.H.; Liu, T.Z.; Wong, C.H.; Lu, F.J.; Chen, S.C. The efficacy of protective effects of tannic acid, gallic acid, ellagic acid, and propyl gallate against hydrogen peroxide-induced oxidative stress and DNA damages in IMR-90 cells. Mol. Nutr. Food Res. 2007, 51, 962–968. [Google Scholar] [CrossRef]
  41. Karaman, S.; Tutem, E.; Baskan, K.S.; Apak, R. Comparison of antioxidant capacity and phenolic composition of peel and flesh of some apple varieties. J. Sci. Food Agric. 2013, 93, 867–875. [Google Scholar] [CrossRef]
  42. Chandra, J.; Samali, A.; Orrenius, S. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 2000, 29, 323–333. [Google Scholar] [CrossRef]
  43. Prasad, M.R.; Lovell, M.A.; Yatin, M.; Dhillon, H.; Markesbery, W.R. Regional membrane phospholipid alterations in Alzheimer’s disease. Neurochem. Res. 1998, 23, 81–88. [Google Scholar] [CrossRef]
  44. Clemens, J.A. Cerebral ischemia: Gene activation, neuronal injury, and the protective role of antioxidants. Free Radic. Biol. Med. 2000, 28, 1526–1531. [Google Scholar] [CrossRef]
  45. Surh, Y.J.; Chun, K.S.; Cha, H.H.; Han, S.S.; Keum, Y.S.; Park, K.K.; Lee, S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: Down-regulation of COX-2 and inos through suppression of NF-κB activation. Mutat. Res. 2001, 480, 243–268. [Google Scholar]
  46. Moncada, S.; Palmer, R.M.; Higgs, E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43, 109–142. [Google Scholar]
  47. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992, 6, 3051–3064. [Google Scholar]
  48. Cuzzocrea, S.; Zingarelli, B.; Hake, P.; Salzman, A.L.; Szabo, C. Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic. Biol. Med. 1998, 24, 450–459. [Google Scholar] [CrossRef]
  49. Beckman, J.S.; Beckman, T.W.; Chen, J.; Marshall, P.A.; Freeman, B.A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 1990, 87, 1620–1624. [Google Scholar]
  50. Rubbo, H.; Radi, R.; Trujillo, M.; Telleri, R.; Kalyanaraman, B.; Barnes, S.; Kirk, M.; Freeman, B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J. Biol. Chem. 1994, 269, 26066–26075. [Google Scholar]
  51. Hanisch, U.K. Microglia as a source and _target of cytokines. Glia 2002, 40, 140–155. [Google Scholar] [CrossRef]
  52. Ponnusankar, S.; Pandit, S.; Venkatesh, M.; Bandyopadhyay, A.; Mukherjee, P.K. Cytochrome p450 inhibition assay for standardized extract of Terminalia chebula Retz. Phytother. Res. 2011, 25, 151–154. [Google Scholar] [CrossRef]
  53. Suchalatha, S.; Srinivasan, P.; Devi, C.S. Effect of T.chebula on mitochondrial alterations in experimental myocardial injury. Chem. Biol. Interact. 2007, 169, 145–153. [Google Scholar] [CrossRef]
  54. Sameermahmood, Z.; Raji, L.; Saravanan, T.; Vaidya, A.; Mohan, V.; Balasubramanyam, M. Gallicacid protects RINm5F beta-cells from glucolipotoxicity by its antiapoptotic and insulin-secretagogue actions. Phytother. Res. 2010, 24, S83–S94. [Google Scholar] [CrossRef]
  55. Moeslinger, T.; Friedl, R.; Volf, I.; Brunner, M.; Koller, E.; Spieckermann, P.G. Inhibition of inducible nitric oxide synthesis by the herbal preparation Padma 28 in macrophage cell line. Can. J. Physiol. Pharmacol. 2000, 78, 861–866. [Google Scholar] [CrossRef]
  56. Cheel, J.; Theoduloz, C.; Rodriguez, J.; Schmeda-Hirschmann, G. Free radical scavengers and antioxidants from lemongrass (Cymbopogon citratus (DC.) Stapf.). J. Agric. Food Chem. 2005, 53, 2511–2517. [Google Scholar] [CrossRef]
  57. Singleton, V.L.; Rossi, J.A., Jr. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 1965, 16, 144–158. [Google Scholar]
  58. Lapchak, P.A.; Maher, P.; Schubert, D.; Zivin, J.A. Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes. Neuroscience 2007, 150, 585–591. [Google Scholar] [CrossRef]
  59. El-Sayed, M.A.; Gameil, N.M.; Shawky, N.M.; Nader, M.A. Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model. Int. Immunopharmacol. 2011, 11, 2232–2236. [Google Scholar] [CrossRef]
  • Sample Availability: Samples of the Terminalia chebula are available from the authors.

Share and Cite

MDPI and ACS Style

Gaire, B.P.; Jamarkattel-Pandit, N.; Lee, D.; Song, J.; Kim, J.Y.; Park, J.; Jung, S.; Choi, H.-Y.; Kim, H. Terminalia chebula Extract Protects OGD-R Induced PC12 Cell Death and Inhibits LPS Induced Microglia Activation. Molecules 2013, 18, 3529-3542. https://doi.org/10.3390/molecules18033529

AMA Style

Gaire BP, Jamarkattel-Pandit N, Lee D, Song J, Kim JY, Park J, Jung S, Choi H-Y, Kim H. Terminalia chebula Extract Protects OGD-R Induced PC12 Cell Death and Inhibits LPS Induced Microglia Activation. Molecules. 2013; 18(3):3529-3542. https://doi.org/10.3390/molecules18033529

Chicago/Turabian Style

Gaire, Bhakta Prasad, Nirmala Jamarkattel-Pandit, Donghun Lee, Jungbin Song, Ji Young Kim, Juyeon Park, Soyoung Jung, Ho-Young Choi, and Hocheol Kim. 2013. "Terminalia chebula Extract Protects OGD-R Induced PC12 Cell Death and Inhibits LPS Induced Microglia Activation" Molecules 18, no. 3: 3529-3542. https://doi.org/10.3390/molecules18033529

APA Style

Gaire, B. P., Jamarkattel-Pandit, N., Lee, D., Song, J., Kim, J. Y., Park, J., Jung, S., Choi, H.-Y., & Kim, H. (2013). Terminalia chebula Extract Protects OGD-R Induced PC12 Cell Death and Inhibits LPS Induced Microglia Activation. Molecules, 18(3), 3529-3542. https://doi.org/10.3390/molecules18033529

Article Metrics

Back to TopTop
  NODES
admin 2
Association 3
Idea 1
idea 1
innovation 2
INTERN 30
Note 6
Project 3
twitter 1